Antibe Therapeutics

From SourceWatch
(Redirected from Antibe)
Jump to navigation Jump to search

"Antibe Therapeutics (“Antibe”) is a public biotech company with a drug platform of game-changing therapeutics in pain and inflammation. Its lead drug, ATB-346, recently showed unequivocal superiority to naproxen in GI safety, and its combined pipeline is targeting a global market opportunity in excess of $20 billion." [1]

Scientific Advisory Board [2]

Resources and articles

Related Sourcewatch

References

  1. Antibe Therapeutics About, organizational web page, accessed August 15, 2018.
  2. Antibe cientific-advisory-board, organizational web page, accessed August 15, 2018.